A prescription refill note records a refill or renewal request handled between visits: what was asked for, what you checked, what you decided, and what the patient was told. Copy the free template, see a blood pressure and cholesterol renewal and an early opioid refill request, and check what goes in each part.
Blank prescription refill note template
FreePRESCRIPTION REFILL NOTE Patient: [Name, date of birth] Date of request: [Date and time received] Request from: [Patient, caregiver, pharmacy renewal request, or portal message] Handled by: [Name, role] Prescriber of record: [Name] THE REQUEST Medicine: [Name, strength, dose, how often, and what it's for] Quantity asked for: [Tablets or days' supply, and refills] Last filled: [Date, quantity, and days' supply, from the pharmacy record] Supply left: [Tablets or days left, by the patient's count or the fill dates] Reason for the request: [Routine renewal, running out early, lost or stolen, a dose change, or travel] ADHERENCE AND RESPONSE How it's taken: [As prescribed, or how the patient actually takes it] Fill history: [On-time, late, or early fills over the past year] Is it working: [Symptoms, home readings, or goals, as the patient reports them] Side effects: [New side effects, or none reported] MONITORING Last visit: [Date, and with whom] Next visit: [Date booked, or when it is due] Labs: [Each test the medicine needs, the last result and its date, and whether it is due] Readings and drug levels: [Blood pressure, heart rate, weight, blood sugar, INR, or drug levels, with the last value and date] SAFETY CHECKS New medicines and interactions: [Prescriptions, over-the-counter products, or supplements since the last review; interactions found, or none] Kidney and liver function: [Last eGFR and liver tests, and whether the dose still fits] Allergies: [Confirmed, with any change] Pregnancy: [Pregnant, planning, or breastfeeding, where it matters, or not applicable] Controlled substances: [Agreement on file; prescription monitoring program checked, with the date and what it showed; last urine drug test; or not applicable] Early refill pattern: [Earlier early requests, lost or stolen reports, more than one prescriber, or none] DECISION Protocol: [The delegated refill protocol used and each criterion met, or routed to the prescriber and why] Decision: [Renewed, renewed a short supply until a visit, declined with a visit booked, or changed] Prescription sent: [Medicine, dose, quantity, refills, and pharmacy, or none] Orders: [Labs, readings, or a visit booked with the renewal] Reason: [Why this decision, in a sentence or two] PATIENT CONTACT Told: [What the patient was told, how, when, and by whom] Response: [What the patient said back, and any questions] When to call sooner: [Side effects, symptoms, or running out before the visit] Approved by: [Prescriber name, credentials, date and time] Note by: [Name, role, date and time]
Use it for
Each one follows the template. Use them to judge how much detail every part needs.
Family practice inbox; electronic renewal request from the pharmacy, prepared by a nurse under the clinic’s refill protocol
Daniel Mensah, 61, born April 3, 1965. Received November 10, 2026, 8:40 a.m.: electronic renewal request from Northside Pharmacy for lisinopril 20 mg, 1 tablet each morning, for high blood pressure, and atorvastatin 20 mg, 1 tablet at bedtime, for high cholesterol. Asked for 90 days of each; no refills left. Last filled August 15, 2026, 90 tablets of each, so he runs out around November 13. Routine renewal. Handled by Alicia Gomez, RN. Prescriber of record: Dr. Hannah Weiss.
Pharmacy fill history: four 90-day fills of each in the past year, all on time. Portal message from Mr. Mensah this morning: takes both every day, with no missed doses that he knows of. No cough, dizziness, or muscle aches. Home blood pressure: 7 morning readings this week on his upper-arm cuff, average 128/79, highest 134/82. His cuff was checked against the office machine in February.
Last visit: February 12, 2026, annual review with Dr. Weiss; blood pressure 126/78. Next visit: annual review due February 2027, not yet booked. Labs: potassium 4.3 mmol/L, eGFR 88, and a lipid panel with LDL 88 mg/dL (2.3 mmol/L), all on September 22, 2025, 14 months ago. The protocol asks for potassium and creatinine within 12 months for an ACE inhibitor, so they are overdue. The lipid panel is due for his annual review.
Medicines: lisinopril, atorvastatin, and acetaminophen as needed. No new medicines on the pharmacy record or in his message. No ibuprofen or naproxen, potassium supplements, or salt substitute, by his report. No interactions flagged. Kidney function: last eGFR 88, but 14 months old; recheck ordered. Allergies: none known, confirmed. Pregnancy: not applicable. Controlled substances: not applicable. Early refill pattern: none.
Protocol: the clinic’s renewal protocol for blood pressure and cholesterol medicines. Met: seen within 12 months, home readings at goal, no side effects, fills on time. Not met: potassium and creatinine older than 12 months, so routed to Dr. Weiss at 9:05 a.m. Decision: Dr. Weiss renewed both for 90 days. Sent to Northside Pharmacy: lisinopril 20 mg, 1 tablet each morning, 90 tablets, no refills; atorvastatin 20 mg, 1 tablet at bedtime, 90 tablets, no refills. Orders: potassium, creatinine, and a lipid panel within 2 weeks. Annual review booked for February 9, 2027, so this supply runs out at the visit, not after it. Reason: 6 years on the same doses, at goal at home, last results normal, and nothing new that raises potassium or strains the kidneys. A result out of range will be acted on long before this supply ends.
Portal message sent at 9:20 a.m. by Alicia Gomez: both medicines renewed for 90 days at Northside Pharmacy; lab requisition attached, no fasting needed; annual review on February 9, 2027, and bring his home readings. Mr. Mensah replied at 11:02 a.m. that he’ll have his blood drawn on Friday. Call sooner for dizziness on standing, swelling of the lips, tongue, or face, or muscle pain he can’t explain. Approved by Dr. Hannah Weiss, MD, November 10, 2026, 9:12 a.m. Note by Alicia Gomez, RN, November 10, 2026, 9:25 a.m.
Primary care nurse line; phone request on day 21 of a 30-day supply, routed to the prescriber
Carla Jensen, 52, born January 30, 1974. Received November 10, 2026, 10:15 a.m., by phone. Medicine: oxycodone 5 mg, 1 tablet up to 3 times a day, for chronic low back pain after a lumbar fusion in 2023; 22.5 morphine milligram equivalents a day. Asked for her next 90 tablets now. Last filled October 20, 2026, 90 tablets for 30 days; next fill due November 19, so 9 days early. Supply left: 6 tablets, by her count. Reason given: her back pain flared 3 weeks ago after she helped her daughter move, and she has taken a fourth tablet every day since. Handled by Marcus Lee, RN. Prescriber of record: Dr. Ruth Abernathy.
3 tablets a day, as agreed, for 19 months; 4 a day for the past 21 days, which is 30 morphine milligram equivalents a day. Pain: PEG score 7 today, up from her usual 4. Walks 10 minutes, down from 30, and missed 2 shifts at the library. The extra tablet takes the edge off for 2 or 3 hours. No new leg pain, numbness, or weakness, and no bladder or bowel changes. Side effects: constipation, managed with senna; no daytime drowsiness.
Last visit: September 8, 2026, with Dr. Abernathy; PEG 4, walking 30 minutes, working 4 shifts a week. Next visit: due December 8, 2026, on the 3-monthly schedule in her agreement. Urine drug test: May 12, 2026, oxycodone and oxymorphone only, as expected. Kidney and liver tests: normal in May 2026.
Agreement on file, signed April 2025: one prescriber, one pharmacy, no early refills without a visit. Prescription monitoring program checked at 10:30 a.m.: oxycodone from Dr. Abernathy only, filled every 30 days at Lakeview Pharmacy, all on schedule; no other controlled medicines or prescribers. Early refill pattern: none before, and no lost or stolen reports. Other medicines: acetaminophen 1,000 mg twice a day and senna at bedtime; no benzodiazepines, sleeping pills, or gabapentin. Alcohol: none. Sleep: no known sleep apnea; her husband hasn’t noticed snoring or pauses in breathing. Mood: low because of the pain; no thoughts of self-harm or suicide. Naloxone: nasal spray in her bedside drawer, in date until 2027; her husband, Tom, knows how to give it. No withdrawal symptoms.
Protocol: controlled substances are excluded from the clinic’s refill protocol; routed to Dr. Abernathy at 10:40 a.m. Decision: early refill declined, as set out in her agreement. In-person visit booked for Thursday, November 12, 2026, at 9:00 a.m., before her 6 tablets run out at 3 a day. Prescription sent: none today. Reason: a first early request with a clear explanation, a monitoring report that matches her account, and no sign of sedation, though she has taken more than prescribed. A flare needs an exam and a plan, not a larger supply by phone, and seeing her before she runs out avoids a gap that would bring on withdrawal. At the visit: examine her back and legs, review the flare and her function, consider physical therapy and other non-opioid options, and decide on the next prescription together.
Dr. Abernathy called Ms. Jensen at 11:05 a.m. Explained why the early refill was declined, and that this isn’t a breach of her agreement or a change in her care. Asked her to go back to 3 tablets a day so the 6 tablets last until Thursday’s visit, to add heat and her stretches, and to keep acetaminophen at no more than 1,000 mg 3 times a day. No alcohol or other sedatives. Naloxone stays where it is, and Tom knows the plan. She said, “I didn’t want to hide it. I’d rather come in.” Go to the emergency department for new leg weakness, numbness in the groin, or bladder or bowel changes. Call the same day if she runs out before the visit, or for sweating, aches, diarrhea, or restlessness. Approved by Dr. Ruth Abernathy, MD, November 10, 2026, 11:15 a.m. Note by Marcus Lee, RN, November 10, 2026, 11:20 a.m.
What was asked for, by whom, and how much is left, taken from the pharmacy record rather than memory.
Avoid: Leaving out the last fill date. It’s the only way to spot an early request, or a patient who stopped the medicine months ago.
Whether the patient takes the medicine as prescribed, and whether it is doing its job.
Avoid: Renewing a medicine the patient isn’t taking. Late fills often mean side effects, cost, or doubt, and a renewal fixes none of them.
The visits, labs, and readings each medicine needs, and whether they are current.
Avoid: “Labs reviewed” with no dates. Write the last result and its date, so anyone can see what is overdue.
What could make the same prescription unsafe now, even if it was right last time.
Avoid: Treating an early request as proof of misuse. Pain flares, dose confusion, and travel are common reasons. Ask, check, and record what you found.
What you decided, under whose authority, and why.
Avoid: A protocol renewal outside the protocol. If one criterion isn’t met, the request goes to the prescriber, and the note says so.
What the patient was told, and who approved the decision.
Avoid: A decline the patient learns about at the pharmacy counter. Tell them yourself, explain why, and give them the next step.
One line tells the next person nothing about what was checked. Record the last fill, the monitoring, the safety checks, and the reason, even when the answer is a routine yes.
An ACE inhibitor, a diuretic, lithium, or levothyroxine renewed for a year without labs is how a high potassium, a toxic level, or the wrong dose goes unseen. Check what each medicine needs, and order it with the renewal.
Most refill protocols exclude opioids, benzodiazepines, and stimulants. Route them to the prescriber, check the prescription monitoring program every time, and write what it showed.
A flat no can leave a patient without a medicine that is dangerous to stop suddenly, such as an opioid, a benzodiazepine, an antiseizure medicine, or a beta-blocker. Book a visit before the supply runs out, or give a short supply to reach it, and say so in the note.
The chart may not know about a new medicine from a specialist, or the ibuprofen bought last week. Check the pharmacy record and ask the patient before calling the interaction check clear.
Vero Scribe drafts the refill note in your template from your dictation, or from the call with the patient’s consent: the request, the monitoring, the safety checks, and the decision. You review and edit every section, then copy it into your record or export it to Word or PDF. Vero works in 60+ languages.
Write down who asked and for what, the last fill date and how much is left, whether the patient takes it as prescribed, and the monitoring the medicine needs, with dates. Add the safety checks, the decision and the protocol or prescriber behind it, the exact prescription sent, and what the patient was told. The template above follows that order.
A refill is the pharmacy dispensing again from a prescription that still has refills on it; the prescriber isn’t involved. A renewal is a new prescription once the refills run out or the prescription expires, and it needs the prescriber, or someone acting under a delegated protocol. Many clinics call both a refill request. This note works for either.
Yes, where your regulator and your organization allow it, under a written refill protocol, standing order, or medical directive signed by the prescribers. The protocol names the medicines it covers, the criteria to check, such as a visit within 12 months, current labs, and readings at goal, and what must go to the prescriber: usually controlled substances, new medicines, dose changes, and any request that fails a criterion. Write the protocol and the criteria checked in the note. In some places, pharmacists can also renew prescriptions on their own authority.
Ask why, and count what’s left. Check the prescription monitoring program and the agreement, and look for earlier early requests. Review safety: sedation, alcohol and other sedatives, mood, and naloxone at home. A first early request with a clear reason is a reason to see the patient, not to end treatment. Many clinicians decline the early fill and book a visit before the supply runs out, so there is no gap and no withdrawal. Record your reasons either way.
It depends on the medicine and how current the monitoring is. For a stable medicine with a recent visit, current labs, and readings at goal, many clinics renew for 90 days. When labs or a visit are overdue, order or book them with the renewal, and size the supply so it runs out at the visit, not after it. A short supply, often 30 days, fits when the patient hasn’t been seen in over a year or something has changed. Write the date it runs out, so one bridge doesn’t turn into a year of bridges.
A telephone encounter note covers any call: symptoms, triage, and advice. A refill note is built around one medicine: the last fill, the monitoring it needs, the safety checks, and a decision on the prescription. If a refill call turns up a new symptom, record that as a telephone encounter or book a visit.
Yes. Copy it, or download it as a Word or text file. No account needed.
The SOAP note reordered: assessment and plan on top, with the history and findings below to back them.
For clinical phone calls and nurse triage: the caller, red flags, advice, disposition, and who calls back.
Your chart note on a lab or imaging result: the value and trend, urgency, action, patient contact, and tracking.
The record of a team or family care conference: attendance, consent, each discipline’s update, decisions, and actions with owners and dates.
For bedside and clinic procedures: indication, consent, time-out, technique, findings, specimens, complications, and aftercare.
A free reconciliation template and checklist for comparing medication sources.
Visit notes, medication changes, and follow-up, drafted for your review.
Counselling conversations turned into notes and care-team updates.
Vero writes your notes and letters in the templates you choose, so you review instead of type.
No credit card required. 10 free actions every month.